Hong Kong · Delayed Price · Currency is HKD BeOne Medicines AG Statistics
Total Valuation
HKG:6160 has a market cap or net worth of HKD 312.97 billion. The enterprise value is 289.06 billion.
| Market Cap | 312.97B |
| Enterprise Value | 289.06B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.36B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +8.01% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 80.95M |
Valuation Ratios
The trailing PE ratio is 60.86 and the forward PE ratio is 42.60.
| PE Ratio | 60.86 |
| Forward PE | 42.60 |
| PS Ratio | 6.51 |
| PB Ratio | 7.71 |
| P/TBV Ratio | 7.81 |
| P/FCF Ratio | 30.00 |
| P/OCF Ratio | 26.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.51, with an EV/FCF ratio of 27.71.
| EV / Earnings | 56.21 |
| EV / Sales | 6.01 |
| EV / EBITDA | 33.51 |
| EV / EBIT | 39.97 |
| EV / FCF | 27.71 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.40.
| Current Ratio | 3.40 |
| Quick Ratio | 2.91 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 1.86 |
| Debt / FCF | 1.54 |
| Interest Coverage | 7.97 |
Financial Efficiency
Return on equity (ROE) is 14.66% and return on invested capital (ROIC) is 33.62%.
| Return on Equity (ROE) | 14.66% |
| Return on Assets (ROA) | 7.46% |
| Return on Invested Capital (ROIC) | 33.62% |
| Return on Capital Employed (ROCE) | 13.08% |
| Weighted Average Cost of Capital (WACC) | 6.87% |
| Revenue Per Employee | 4.01M |
| Profits Per Employee | 428,510 |
| Employee Count | 12,000 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.10 |
Taxes
In the past 12 months, HKG:6160 has paid 1.67 billion in taxes.
| Income Tax | 1.67B |
| Effective Tax Rate | 24.46% |
Stock Price Statistics
The stock price has decreased by -1.43% in the last 52 weeks. The beta is 0.50, so HKG:6160's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -1.43% |
| 50-Day Moving Average | 204.83 |
| 200-Day Moving Average | 191.49 |
| Relative Strength Index (RSI) | 43.66 |
| Average Volume (20 Days) | 3,719,698 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.49 |
Income Statement
In the last 12 months, HKG:6160 had revenue of HKD 48.06 billion and earned 5.14 billion in profits. Earnings per share was 43.83.
| Revenue | 48.06B |
| Gross Profit | 42.73B |
| Operating Income | 7.24B |
| Pretax Income | 6.81B |
| Net Income | 5.14B |
| EBITDA | 8.40B |
| EBIT | 7.24B |
| Earnings Per Share (EPS) | 43.83 |
Balance Sheet
The company has 39.98 billion in cash and 16.07 billion in debt, with a net cash position of 23.91 billion.
| Cash & Cash Equivalents | 39.98B |
| Total Debt | 16.07B |
| Net Cash | 23.91B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 40.58B |
| Book Value Per Share | 359.00 |
| Working Capital | 39.97B |
Cash Flow
In the last 12 months, operating cash flow was 11.64 billion and capital expenditures -1.21 billion, giving a free cash flow of 10.43 billion.
| Operating Cash Flow | 11.64B |
| Capital Expenditures | -1.21B |
| Depreciation & Amortization | 1.16B |
| Net Borrowing | 849.76M |
| Free Cash Flow | 10.43B |
| FCF Per Share | n/a |
Margins
Gross margin is 88.89%, with operating and profit margins of 15.06% and 10.70%.
| Gross Margin | 88.89% |
| Operating Margin | 15.06% |
| Pretax Margin | 14.16% |
| Profit Margin | 10.70% |
| EBITDA Margin | 17.48% |
| EBIT Margin | 15.06% |
| FCF Margin | 21.71% |
Dividends & Yields
HKG:6160 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.01% |
| Shareholder Yield | -8.01% |
| Earnings Yield | 1.64% |
| FCF Yield | 3.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:6160 is 263.44, which is 27.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 263.44 |
| Price Target Difference | 27.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | 17.69% |
| EPS Growth Forecast (3Y) | 81.75% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:6160 has an Altman Z-Score of 5.65 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.65 |
| Piotroski F-Score | 7 |